Coriell Life Sciences (CLS) has developed a Genomic Data Ecosystem that offers storage of genomic data, expert interpretation and an interchange framework that delivers clinically-relevant genomic interpretation at the point-of-care.
Anchored by an ongoing partnership with the Coriell Institute for Medical Research and IBM, CLS was formed to scale-up the robust framework and process architecture developed for the Coriell Personalized Medicine Collaborative (CPMC).
Bringing together more than 6,000 study participants, physicians, scientists, ethicists, genetic counselors and information technologists, the CPMC is a long-term research study designed to determine the utility of personal genome information in health management and clinical decision-making.
CLS is leveraging the framework of the CPMC to fill the gap between doctors, sequence providers, and scientists with expertise in genome interpretation. Our three core products – GeneVault, GeneExchange, and GeneDose – allow providers to order genomic sequencing, access expert interpretations, and securely store data for further interpretation when needed.
These products make it possible for healthcare systems and their providers to seamlessly integrate genomic data into first-class clinical delivery using cutting-edge sequencing technology and information management to deliver the desired information at the point of care.
Coriell Life Sciences Partners
Coriell Life Sciences
Coriell Life Sciences (CLS) is a cutting-edge venture focused on empowering physicians to apply genetic analyses at point-of-care. [ Learn More › ]
The Coriell Institute for Medical Research, founded in 1953 and based in Camden, New Jersey, is an independent non-profit research center dedicated to the study of the human genome. [ Learn More › ]
Coriell Life Sciences (CLS) has partnered with IBM to tackle the 'big data' challenges inherent in genomics. [ Learn More › ]